The shareholders approved the merger agreement in a majority vote at a special meeting Oct. 29. LifePoint expects the deal to close in the fourth quarter of this year.
Although shareholders agreed to the merger, they did not affirm a proposed “golden parachute” compensation package that would pay out approximately $120 million to four of LifePoint’s top executives after the transaction closes.
Because the vote on the compensation package is advisory, it is nonbinding as long as the LifePoint-RCCH merger is finalized, according to the SEC filing.
More articles on healthcare finance:
Moody’s: How CHS, Tenet and LifePoint are offsetting industry challenges
Amazon, Apple join growing list of companies opening on-site clinics for employees
Arizona hospital rebrands after bankruptcy
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
